Lomond Therapeutics Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Lomond Therapeutics Holdings, Inc. |
| Form Type | 10-Q |
| Filed Date | May 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Lomond Therapeutics (LMT) filed its Q1 2025 10-Q. Check financials.
AI Summary
Lomond Therapeutics Holdings, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as Venetian-1 Acquisition Corp., is incorporated in Delaware and operates in the pharmaceutical preparations sector. Its principal executive offices are located in Dover, Delaware, and its telephone number is (212) 739-6400.
Why It Matters
This filing provides investors with an update on Lomond Therapeutics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing providing financial and operational updates, not indicating immediate significant risk.
Key Players & Entities
- Lomond Therapeutics Holdings, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- Venetian-1 Acquisition Corp. (company) — Former company name
- Delaware (location) — State of incorporation and principal executive offices
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- 000-56377 (filing_id) — Commission file number
- (212) 739-6400 (phone_number) — Registrant's telephone number
FAQ
What is the reporting period for this 10-Q filing?
The quarterly period ended March 31, 2025.
What was Lomond Therapeutics Holdings, Inc. formerly known as?
The company was formerly known as Venetian-1 Acquisition Corp.
In which state is Lomond Therapeutics Holdings, Inc. incorporated?
The company is incorporated in Delaware.
What is the Standard Industrial Classification code for Lomond Therapeutics Holdings, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the commission file number for Lomond Therapeutics Holdings, Inc.?
The commission file number is 000-56377.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding Lomond Therapeutics Holdings, Inc..